companydata.dkcompanydata.dk

PFIZER ApS: Financial statements 2022

CVR: 66351912

Source: annual report 2022, Danish Business Authority

01/12/202130/11/2022

PFIZER ApS (CVR 66351912) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 2,299,853,000 and a net result of DKK 92,036,000 compared with DKK 106,063,000 the year before. That is an increase of 45.5% compared with the year before. The profit margin was 4%. Equity in the 2022 report amounted to DKK 395,080,000. The solvency ratio was 29.7%. The company had 119 employees in the financial year.

Revenue
DKK 2,299,853,000
Gross Profit
DKK 243,133,000
Profit/Loss
DKK 92,036,000
Equity
DKK 395,080,000
Total Assets
DKK 1,330,674,000
Employees
119

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20222.3 mia.243.1 mio.92 mio.395.1 mio.119
20211.6 mia.256.2 mio.106.1 mio.483 mio.119
2020319.9 mio.125.1 mio.29 mio.302.2 mio.107
2019421.7 mio.142.9 mio.19 mio.443.2 mio.136
2018459.7 mio.144.6 mio.21.8 mio.424.2 mio.137

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PFIZER ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PFIZER ApS: The 2021 annual report is outMay 2, 2022

PFIZER ApS has published its annual report for 2021. Revenue came to DKK 1,580,587,000, and the net result was DKK 106,063,000.

Kjetil Hagen joins the board of PFIZER ApSApr 28, 2022

As of April 28, 2022, Kjetil Hagen has joined the board of directors of PFIZER ApS.

Stefano Podestá leaves the board of PFIZER ApSMar 9, 2022

As of March 9, 2022, Stefano Podestá has left the board of directors of PFIZER ApS.

About PFIZER ApS

PFIZER ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 1956. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Kjetil Hagen. The board consists of Anne Bloch Thomsen (chair), Hans Henrik Buur and Kjetil Hagen. The company is owned by Pfizer Health AB. The company has 148 employees (2018). In 2025, the company reported revenue of DKK 683,240,000 and a net result of DKK 13,956,000 compared with DKK 13,103,000 the year before. Equity in the 2025 report amounted to DKK 315,053,000.

Source: annual report 2025, Danish Business Authority